Melissa Frizziero

Manchester, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Tumour acquisition method and molecular profiling success in advanced cholangiocarcinoma.

Tumour acquisition method and molecular profiling success in advanced cholangiocarcinoma.

Journal: Acta oncologica (Stockholm, Sweden)

Published: January 27, 2026

ABC-12: exploring the microbiome in patients with advanced biliary tract cancer in a first-line study of durvalumab (MEDI4736) in combination with cisplatin/gemcitabine.

ABC-12: exploring the microbiome in patients with advanced biliary tract cancer in a first-line study of durvalumab (MEDI4736) in combination with cisplatin/gemcitabine.

Journal: Future oncology (London, England)

Published: July 29, 2025

Antibody-Drug Conjugates and Their Potential in the Treatment of Patients with Biliary Tract Cancer.

Antibody-Drug Conjugates and Their Potential in the Treatment of Patients with Biliary Tract Cancer.

Journal: Cancers

Published: August 31, 2024

Systemic Therapy for Metastatic Pancreatic Cancer-Current Landscape and Future Directions.

Systemic Therapy for Metastatic Pancreatic Cancer-Current Landscape and Future Directions.

Journal: Current oncology (Toronto, Ont.)

Published: July 03, 2024

Prevalence of CDKN2A, CDK4, POT1, BAP1, MITF, ATM, and TERT Pathogenic Variants in a Single-Center Retrospective Series of Patients With Melanoma and Personal or Family History Suggestive of Genetic Predisposition.

Prevalence of CDKN2A, CDK4, POT1, BAP1, MITF, ATM, and TERT Pathogenic Variants in a Single-Center Retrospective Series of Patients With Melanoma and Personal or Family History Suggestive of Genetic Predisposition.

Journal: Dermatology practical & conceptual

Published: February 01, 2024

Relevant Study: Patient and Clinician Perspectives on Clinically-Meaningful Outcomes in Advanced Pancreatic Cancer.

Relevant Study: Patient and Clinician Perspectives on Clinically-Meaningful Outcomes in Advanced Pancreatic Cancer.

Journal: Cancers

Published: November 17, 2022

The Management and Outcomes of Patients with Extra-Pulmonary Neuroendocrine Neoplasms and Brain Metastases.

The Management and Outcomes of Patients with Extra-Pulmonary Neuroendocrine Neoplasms and Brain Metastases.

Journal: Current oncology (Toronto, Ont.)

Published: June 10, 2022

Molecular Profiling of Well-Differentiated Neuroendocrine Tumours: The Role of ctDNA in Real-World Practice.

Molecular Profiling of Well-Differentiated Neuroendocrine Tumours: The Role of ctDNA in Real-World Practice.

Journal: Cancers

Published: December 13, 2021

Expanding Therapeutic Opportunities for Extrapulmonary Neuroendocrine Carcinoma.

Expanding Therapeutic Opportunities for Extrapulmonary Neuroendocrine Carcinoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: August 24, 2021

Is the Morphological Subtype of Extra-Pulmonary Neuroendocrine Carcinoma Clinically Relevant?

Is the Morphological Subtype of Extra-Pulmonary Neuroendocrine Carcinoma Clinically Relevant?

Journal: Cancers

Published: August 03, 2021

Fibrolamellar carcinoma: Challenging the challenge.

Fibrolamellar carcinoma: Challenging the challenge.

Journal: European journal of cancer (Oxford, England : 1990)

Published: June 15, 2020

Prognostic importance of lymph node yield after curative resection of gastroenteropancreatic neuroendocrine tumours.

Prognostic importance of lymph node yield after curative resection of gastroenteropancreatic neuroendocrine tumours.

Journal: World journal of clinical oncology

Published: December 24, 2019

Showing 1-12 of 32

Last Updated: 09/26/2026